Supplies it“Our target markets include operators of commercial LWRs as well as developers and operators of advanced nuclear reactor technologies, including SMRs and MMRs.”
In development“The fast fission reactor technology we are commercializing was demonstrated by the Experimental Breeder Reactor-II (“EBR-II”), a fast fission plant that was operated by the U.S. government for 30 years.”
Latest 10-KFY2025Positive ·
Share offerings funded rising Aurora and fuel-development spending; Meta’s Ohio prepayment agreement advanced the project pipeline.
Revenue—
Net income−$105.7MYoY −43.5%
Latest 10-QQ3 FY2026Positive ·
Aurora-ID advanced through safety reviews, while acquired engineering businesses supplied nearly all revenue.
Revenue$1.9Mvs $0 year ago
Net income−$41.7MYoY −40.5%
Latest 8-KPositiveContract / partnership ·
Centrus HALEU deal includes $35M in prepayments to support enrichment expansion for Aurora powerhouses, with deliveries in 2029–2031.
Latest 8-KEquity raise ·
New $1.0B at-the-market stock program replaces the prior agreement after ≈$1.0B in share sales.
Latest 8-KLeadership change ·
Five executive appointments include Alexandra Renner as Chief Product Officer; existing employment arrangements continue.
Latest 8-KShareholder vote ·
Stockholders elected all Class II director nominees and ratified Deloitte & Touche as FY2026 auditor.
Sells it 96%, $30.1M a year“NuScale is redefining nuclear power through the development of proprietary and innovative SMR technology that the Company believes will deliver safe, scalable, cost-effective and reliable carbon-free power.”
Latest 10-KFY2025MixedImpairment / charge ·
ENTRA1’s non-binding 72-module agreement triggered a $507M expense before any binding NuScale equipment order.
Revenue$31.5MYoY −15.0%
Net income−$355.8MYoY −160.4%
Latest 10-QQ3 FY2026MixedLegal / investigation ·
Reactor production spending ramps ahead of binding orders as ENTRA1 projects hinge on power deals and RoPower awaits financing.